[Current data on the screening of malignant hyperthermia during anesthesia]
- PMID: 7995103
[Current data on the screening of malignant hyperthermia during anesthesia]
Abstract
A rare complication of general anesthesia, malignant hyperthermia is nonetheless very topical because it causes the death of young, healthy subjects who most often undergo surgery with no vital risk. Screening, an essential means of achieving riskless anesthesia, is based on testing on fresh biopsy specimens of muscle. The current state of knowledge, especially the progress made in genetics, will be commented.
Similar articles
-
Malignant hyperthermia in China.Anesth Analg. 2006 Oct;103(4):983-5. doi: 10.1213/01.ane.0000237289.66136.cd. Anesth Analg. 2006. PMID: 17000816
-
Halothane-caffeine contracture testing in neuromuscular diseases.Muscle Nerve. 1988 May;11(5):453-7. doi: 10.1002/mus.880110507. Muscle Nerve. 1988. PMID: 3374516
-
A case of neuroleptic malignant syndrome: in vitro muscle comparison with malignant hyperthermia.J Clin Psychopharmacol. 1982 Aug;2(4):266-70. J Clin Psychopharmacol. 1982. PMID: 6126494 No abstract available.
-
[Malignant hyperthermia].Tunis Med. 2002 Jul;80(7):395-401. Tunis Med. 2002. PMID: 12611349 Review. French.
-
Preanesthetic diagnosis of malignant hyperthermia.Int Anesthesiol Clin. 1979 Winter;17(4):63-96. doi: 10.1097/00004311-197917040-00006. Int Anesthesiol Clin. 1979. PMID: 391722 Review. No abstract available.